Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | THRB | P10828 | 2/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4856614 | 0.84 | GAA (0.43) | GAACYP3A4CYP2C9CYP2C19SMN1; SMN2 | |
| SCHEMBL4856619 | 0.84 | GAA (0.43) | GAACYP3A4CYP2C9CYP2C19SMN1; SMN2 | |
| SCHEMBL4848464 | 0.76 | SMN1; SMN2 (0.53) | GAASMN1; SMN2MAPTTHRBL3MBTL1 | |
| SCHEMBL5712075 | 0.76 | SMN1; SMN2 (0.53) | GAASMN1; SMN2MAPTTHRBL3MBTL1 | |
| SCHEMBL4856844 | 0.75 | MAPT (0.54) | GAACYP3A4CYP2C9CYP2C19SMN1; SMN2 | |
| SCHEMBL4845951 | 0.75 | MAPT (0.43) | GAACYP3A4CYP2C9CYP2C19SMN1; SMN2 | |
| SCHEMBL4856854 | 0.75 | MAPT (0.54) | GAACYP3A4CYP2C9CYP2C19SMN1; SMN2 | |
| SCHEMBL4845948 | 0.75 | MAPT (0.43) | GAACYP3A4CYP2C9CYP2C19SMN1; SMN2 | |
| SCHEMBL4853481 | 0.74 | MAPT (0.42) | GAACYP3A4CYP2C9CYP2C19SMN1; SMN2 | |
| SCHEMBL4855188 | 0.74 | MAPT (0.42) | GAACYP3A4CYP2C9CYP2C19SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1724275-B1 | PROCESS FOR PRODUCING AMINOPHOSPHONIC ACID DERIVATIVE | JAPAN SCIENCE & TECH AGENCY (JP) | 2015-04-08 | — | — | EP | disclosed |
| US-7375244-B2 | Production method for aminophosphonic acid derivatives | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2008-05-20 | — | — | US | disclosed |
| US-7375244-B2 | Production method for aminophosphonic acid derivatives | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2008-05-20 | — | — | US | disclosed |
| US-20070142658-A1 | Production method for aminophosphonic acid derivatives | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2007-06-21 | — | — | US | disclosed |
| US-20070142658-A1 | Production method for aminophosphonic acid derivatives | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2007-06-21 | — | — | US | disclosed |
| EP-1724275-A1 | PROCESS FOR PRODUCING AMINOPHOSPHONIC ACID DERIVATIVE | Japan Science and Technology Agency (JP) | 2006-11-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070142658-A1 | Production method for aminophosphonic acid derivatives | AASDHPPT, NPEPPS, DAO | GAA 1150/4885CYP3A4 1087/4885CYP2C9 762/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.